Drug
Lenacapavir Sodium
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Injection Site Nodule | 111 | 463.3 | 609.5 | signal |
| 2 | Injection Site Mass | 36 | 44.4 | 48.0 | signal |
| 3 | Injection Site Discomfort | 9 | 39.6 | 40.4 | signal |
| 4 | Injection Site Pain | 137 | 20.5 | 28.7 | signal |
| 5 | Product Administered At Inappropriate Site | 7 | 17.5 | 17.8 | signal |
| 6 | Injection Site Erythema | 40 | 14.7 | 16.0 | signal |
| 7 | Injection Site Swelling | 24 | 14.4 | 15.1 | signal |
| 8 | Injection Site Irritation | 4 | 14.4 | 14.5 | signal |
| 9 | Injection Site Induration | 4 | 14.0 | 14.1 | signal |
| 10 | Injection Site Warmth | 5 | 11.0 | 11.1 | signal |
| 11 | Injection Site Discolouration | 3 | 11.0 | 11.0 | signal |
| 12 | Injection Site Bruising | 15 | 8.6 | 8.9 | signal |
| 13 | Injection Site Reaction | 12 | 7.9 | 8.1 | signal |
| 14 | Injection Site Haemorrhage | 9 | 5.1 | 5.2 | signal |